Holen Sie sich die Stockscreener-App
4.05
1.94%
-0.08
Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
48.91%
36.19
|
24.30 | 21.97 | 24.42 | 19.15 |
| Depreciation and Amortization |
4.08%
0.051
|
0.049 | 0.049 | 0.05 | 0.053 |
| Operating Income/Loss |
48.91%
-36.19
|
-24.30 | -21.97 | -24.42 | -19.15 |
| Nonoperating Income/Loss |
13.63%
1.153
|
1.335 | 1.411 | 1.075 | 1.49 |
| Net Income/Loss |
52.54%
-35.04
|
-22.97 | -20.55 | -23.34 | -17.66 |
| Basic Average Shares |
3.75%
19.41
|
18.71 | 1.0668 | 12.31 | 12.24 |
| Diluted Average Shares |
3.75%
19.41
|
18.71 | 1.0668 | 12.31 | 12.24 |
| Basic Earnings Per Share |
47.15%
-1.81
|
-1.23 | -1.17 | -1.90 | -1.44 |
| Diluted Earnings Per Share |
47.15%
-1.81
|
-1.23 | -1.17 | -1.90 | -1.44 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):